Literature DB >> 2410417

Androgen regulation of MAK mRNAs in mouse kidney.

L D Snider, D King, J B Lingrel.   

Abstract

Androgen-regulated changes in the abundance of two mRNAs in mouse kidney have been studied with the aid of a cDNA clone. The clone was isolated from a library prepared using poly(A+) RNA from kidneys of androgen-induced mice and is designated MAK-I. Unique DNA sequence from MAK-I hybridizes to multiple RNAs which are approximately 1600 and 2200 nucleotides long, and Southern blot analysis of genomic DNA suggests that there is a single gene from which the RNAs are transcribed. When the MAK RNAs are isolated by hybrid selection and translated in a cell-free system, one polypeptide of 42,000 daltons is obtained. The transcripts, in combination, comprise approximately 0.2% of poly(A+) RNA in the kidneys of male mice. Following treatment with testosterone, this level increases 3-fold. The uninduced level of MAK mRNA in female kidneys is half of that exhibited by males and is increased 8-fold by testosterone. The mRNAs are also present and their abundance is hormonally controlled in the liver. Levels of MAK RNA detected in submaxillary gland, heart, brain, muscle, and testes are unaffected by testosterone treatment. Differences in the relative amounts of the different sized mRNAs are observed for several tissues. In addition, brain and muscle contain an intermediate sized mRNA instead of the smaller one seen in other tissues. Functional androgen receptor is required for expression of MAK RNA in kidney as shown by reduced levels in Tfm mice. Hormones produced by or controlled by the pituitary gland do not appear to be involved in the regulation of MAK RNA levels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Proteomic analysis of mouse kidney peroxisomes: identification of RP2p as a peroxisomal nudix hydrolase with acyl-CoA diphosphatase activity.

Authors:  Rob Ofman; Dave Speijer; René Leen; Ronald J A Wanders
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

2.  Molecular genetics of androgen-inducible RP2 gene transcription in the mouse kidney.

Authors:  C Rheaume; K W Barbour; J Tseng-Crank; F G Berger
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

3.  Amino acid sequence of the testosterone-regulated mouse kidney RP2 protein deduced from its complementary DNA sequence.

Authors:  D King; Y H Sun; J B Lingrel
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

4.  Polymorphism in an androgen-regulated mouse gene is the result of the insertion of a B1 repetitive element into the transcription unit.

Authors:  D King; L D Snider; J B Lingrel
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

5.  Tissue- and species-specific regulation of murine alpha 1-antitrypsin gene transcription.

Authors:  C Rheaume; J J Latimer; H Baumann; F G Berger
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

6.  Nudt19 is a renal CoA diphosphohydrolase with biochemical and regulatory properties that are distinct from the hepatic Nudt7 isoform.

Authors:  Stephanie A Shumar; Evan W Kerr; Werner J Geldenhuys; Grace E Montgomery; Paolo Fagone; Puchong Thirawatananond; Harry Saavedra; Sandra B Gabelli; Roberta Leonardi
Journal:  J Biol Chem       Date:  2018-01-29       Impact factor: 5.157

7.  Genetic variations in kinetic constants that describe beta-glucuronidase mRNA induction in androgen-treated mice.

Authors:  G Watson; K Paigen
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

8.  mRNA synthesis rates in vivo for androgen-inducible sequences in mouse kidney.

Authors:  G Watson; K Paigen
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

9.  Androgen regulation of the androgen receptor coregulators.

Authors:  Alfonso Urbanucci; Kati K Waltering; Hanna E Suikki; Merja A Helenius; Tapio Visakorpi
Journal:  BMC Cancer       Date:  2008-08-01       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.